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ABSTRACT
Background: Frailty is an important geriatric syndrome, but little is known about its development in the years preceding onset of the syndrome. 
The aim of this study was to examine the progression of frailty and compare the trajectories of each frailty component prior to frailty onset.
Methods: Repeat data were from two cohort studies: the Longitudinal Aging Study Amsterdam (n = 1440) with a 15-year follow-up and the 
InCHIANTI Study (n = 998) with a 9-year follow-up. Participants were classified as frail if they had >3 frailty components (exhaustion, slowness, 
physical inactivity, weakness, and weight loss). Transitions between frailty components were examined with multistate modeling. Trajectories of 
frailty components were compared among persons who subsequently developed frailty to matched nonfrail persons by using mixed effects models.
Results: The probabilities were 0.43, 0.40, and 0.36 for transitioning from 0 to 1 frailty component, from 1 component to 2 components, and 
from 2 components to 3–5 components (the frail state). The transition probability from frail to death was 0.13. Exhaustion separated frail 
and nonfrail groups already 9 years prior to onset of frailty (pooled risk ratio [RR] = 1.53, 95% confidence interval [CI] 1.04–2.24). Slowness 
(RR = 1.94, 95% CI 1.44–2.61), low activity (RR = 1.59, 95% CI 1.19–2.13), and weakness (RR = 1.39, 95% CI 1.10–1.76) separated frail 
and nonfrail groups 6 years prior to onset of frailty. The fifth frailty component, weight loss, separated frail and nonfrail groups only at the 
onset of frailty (RR = 3.36, 95% CI 2.76–4.08).
Conclusions: Evidence from two cohort studies suggests that feelings of exhaustion tend to emerge early and weight loss near the onset of 
frailty syndrome.
Keywords: Frailty, Exhaustion, Walking speed, Physical activity, Muscle strength.
Introduction
Frailty increases the risk of disability, falls, fractures, institution-
alization, and death (1–5) and is an important public health con-
cern as populations are aging (6). A consensus group consisting of 
international experts has defined frailty as “a medical syndrome 
with multiple causes and contributors that is characterized by 
diminished strength, endurance, and reduced physiologic function 
that increases an individual’s vulnerability for developing increased 
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dependency and/or death” (7). Although often accompanied with 
disabilities and multimorbidity, frailty is its own entity designated 
as a state of increased vulnerability due to impairments in multiple 
systems (7–11). In many studies, frailty is adjudicated according to 
the phenotypic criteria developed by Fried and colleagues, which 
include five components: weight loss, exhaustion, low physical activ-
ity, weakness, and slowness (1). Presence of three or more of these 
components defines frailty, whereas one or two components denote 
prefrailty, and none indicates no frailty.
Much research on frailty has focused on the causes and risk of 
adverse outcomes associated with this condition. In contrast, com-
paratively little is known about the typical sequence by which frailty 
components emerge and cumulate prior to frailty onset. Previous 
studies have examined the dynamic nature of frailty in terms of pro-
gression from no frailty to prefrailty and to frailty and shown that 
frailty is characterized by recurrent transitions between frailty states 
over time (12–16). Most changes between frailty states occurred grad-
ually, and some participants improved and reversed some of the com-
ponents (13). However, to date, we do not know whether and when 
there are specific components that are more likely to emerge prior to 
frailty development. This information is essential to understand the 
natural course of frailty development in people who develop frailty 
syndrome and would help in early identification of individuals at risk 
who are more likely to benefit from preventive interventions.
In this study, we sought to characterize prospectively the emer-
gence of the frailty components based on the phenotypic model by 
modeling transitions between frailty states over a 9- to 15-year fol-
low-up. We also examined in a retrospective setting the differences 
in longitudinal trajectories of each frailty component prior to frailty 
onset between people developing frailty compared with matched 
controls who remained free of frailty.
Methods
Study Populations
Data were from two long-term cohort studies, namely the 
Longitudinal Aging Study Amsterdam (LASA) from the Netherlands 
and the Invecchiare in Chianti, aging in the Chianti area 
(InCHIANTI) study from Italy, in which information on all frailty 
components based on the phenotypic model to frailty has been col-
lected repeatedly at 3-year intervals.
LASA is an ongoing study on physical, emotional, cognitive, 
and social functioning of Dutch older adults. The sampling proced-
ure and data collection of this study have been described elsewhere 
(17,18). In brief, a nationally representative survey was conducted in 
1992–1993 among 3,107 respondents aged 55–84 years. Follow-up 
measurements were collected approximately every 3 years. In each 
wave, data were collected by trained interviewers who visited the 
respondents at home. For the current study, we used data from six 
waves (1995–1996, 1998–1999, 2001–2002, 2005–2006, 2008–
2009, 2011–2012) consisting of measures of all frailty components. 
From the 2,545 LASA respondents at wave 1995–1996 those aged 
65 and over were invited for the medical interview (n = 1,722) and 
of which 1,506 participated.
The InCHIANTI Study is an epidemiologic study of risk factors 
of mobility disability in old age. The study design and data collection 
have been previously described in detail (19). In brief, out of the ran-
dom sample of 1,260 persons aged 65 years and older, 1,155 agreed 
to participate in the study at baseline in 1998–2000. Thereafter, 
participants have been followed up every 3 years. For the current 
study, data were used from all four measurement waves available 
(1998–2000, 2001–2003, 2004–2006 and 2007–2008).
For the prospective part of our analyses, we included partici-
pants who had information on frailty status available at least in two 
study waves and those who had frailty status available once and 
had died by the end of year 2015 (n = 1,440 in LASA and n = 998 
in InCHIANTI). For the retrospective part of the study, we included 
participants if they were not classified as frail (three of more criteria) 
at baseline and had at least one other frailty measurement available 
in the following measurement waves (n = 981 in LASA and n = 765 
in InCHIANTI). Those who developed frailty during the follow-
up were categorized as frailty (n  =  301 in LASA and n  =  214 in 
InCHIANTI), and we then randomly selected 1–2 nonfrail controls 
for each frailty case separately in both studies (n = 515 in LASA and 
n = 339 in InCHIANTI) matching for sex, age group at the end of 
follow-up (5-year bands) and education.
Both the LASA and InCHIANTI studies are conducted in line 
with the Declaration of Helsinki, and participants in both studies 
received an extensive description of the study and participated after 
providing written informed consent. LASA was approved by the 
medical ethics committee of the VU University Medical Center, and 
the InCHIANTI study was approved by the ethical committee of the 
Italian National Institute of Research and Care on Aging.
Measurement of Frailty
Frailty was ascertained using five components and criteria proposed 
by Fried colleagues (1), namely exhaustion, slowness, low physical 
activity, weakness, and weight loss. All components and the frailty 
summary score were measured at each of the study waves in the 
LASA and InCHIANTI studies. The detailed description of the meas-
urements is presented in Supplementary Table 1. A total frailty score 
at each study wave was calculated by allocating a value of 1 to each 
of the above components if present (range 0 to 5). When a partici-
pant met at least three of five of the frailty components, s/he was 
defined “frail” and information on individual frailty criteria from 
the preceding waves was used in the analyses (1). If a participant did 
not develop three or more frailty components over the follow-up, s/
he was categorized into “nonfrail” group and information on indi-
vidual frailty components from all available waves was used in the 
analyses.
Covariates
Age and sex were used as covariates in both study settings. In the 
prospective part of the study, age was modeled as time-varying con-
tinuous variable, whereas in the retrospective part, age as a con-
tinuous variable at the last measurement point was used. In the 
retrospective part, the highest level of education was obtained from 
the baseline and was further categorized into low (<9 years), middle 
(9–12 years), and high (≥ 13 years) in both studies.
Statistical Analysis
We reported characteristics of the study population in prospective 
and retrospective modeling as mean and standard deviation (SD) 
for continuous variables and percentages for categorical variables 
in both cohorts. In the retrospective part, differences across frailty 
groups were examined with t-test for continuous variables and chi-
square for categorical variables. There were six data waves in the 
15-year follow-up of LASA study and four data waves in the 9-year 
follow-up of the InCHIANTI study.
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In prospective analyses, we used the msm package for R for pro-
spective multistate modeling to estimate transitions between frailty 
states (0, 1, 2, 3–5 components) and death (20). In these analyses, 
data from the LASA and InCHIANTI studies were pooled into a 
single dataset and analysis were adjusted for sex, age, and cohort.
In the retrospective part, we divided participants into two 
groups: those who developed (cases) and those who did not develop 
frailty (controls matched by sex, age group in 5-year bands at the 
end of follow-up, and education) during the follow-up period. We 
used a backward timescale, such that year = 0 in the analysis was 
the year of frailty onset for frailty cases and the end of follow-up 
for nonfrail controls that remained free of frailty during the follow-
up. Participants were then traced backward to their first measure-
ment wave. Data at each wave during this retrospective observation 
period were collated to build trajectories for each frailty component 
(exhaustion, slowness, low physical activity, weakness, and weight 
loss) and the total number of frailty components separately for those 
in the “frail” and “nonfrail” groups. This was done by using mixed 
effects models (21) with the intercept as random effects and a back-
ward timescale. Normal distribution was used for continuous and 
Poisson distribution for dichotomous outcomes (22,23). The analy-
ses were adjusted for sex, age, and education. We used contrast state-
ments to detect when the prevalence of an individual component 
and the total number of frailty components diverged significantly 
between the two groups. Results were presented as risk ratios (RRs), 
and their 95% confidence intervals (CI) at each wave with the “non-
frail” group as the reference.
We examined interaction effects of sex and frailty status (at the 
end of follow-up) on development of each frailty component by 
using mixed effects models but found them to be nonsignificant, and 
thus, results are presented for men and women combined and adjust-
ing for sex. After separate analyses in both cohorts, we used fixed-
effects meta-analysis (24) to pool the cohort-specific results into 
summary estimates. In addition, we conducted a sensitivity analysis 
to examine the potential effect of attrition to our results by includ-
ing only participants who had at least a 9-year follow-up available. 
Trajectories of individual frailty components and the total number 
of components were plotted separately for those in the “frail” and 
“nonfrail” groups, and the cohort-specific results were pooled by 
using fixed-effects meta-analysis into summary estimates.
Statistical analyses were performed by using SAS 9.4 Statistical 
Package (SAS Institute Inc., Cary, NC) and the R 3.3.1 statistical 
package.
Results
In the prospective study setting for multistate modeling, 51% were 
women in LASA and 55% in InCHIANTI, and mean age of the 
participants at baseline was 75.7  years in LASA and 74.8  years 
in InCHIANTI. Of the participants, 41% in LASA and 45% in 
InCHIANTI had no frailty components, 44% and 45% had one or 
two frailty components, and 15% and 11% had three or more frailty 
components and were classified as frail at baseline. Prevalence of 
frailty was relatively constant over the follow-up with the amount 
of nonfrail participants transitioning to frailty being equal to the 
amount frail people who died (Figure 1).
Figure  2 provides transition probabilities between frailty 
states and death during the 9–15 years of follow-up in the two 
cohorts combined. The probabilities were 0.44, 0.42, and 0.37 for 
transitioning from 0 to 1 frailty component, from 1 component 
to 2 components, and from 2 components to 3–5 components 
(the frail state). The corresponding transition rate from frail to 
death was 0.13. As expected, accumulating frailty components 
over time was more common than reducing frailty components. 
The hazard ratio of transitioning from a less advantaged state 
Figure  1. Observed prevalence of the number of frailty components and 
death in LASA study with 18-year follow-up (A) and the InCHIANTI study with 
12-year follow-up (B).
Figure 2. Transition probabilities between the number of frailty components 
and death. Pooled study populations based on the LASA and InCHIANTI 
studies (n = 1,438). Analysis adjusted for age, sex, and study cohort.
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to a more advantaged state compared with transitioning from a 
more advantaged state to a less advantaged state was 1.68 (95% 
CI 1.50–1.88) between states of 0 and 1 components, 1.21 (95% 
CI 1.08–1.37) between one and two components, 1.61 (95% CI 
1.38–1.89) between two components and being frail (ie, having 
three or more components).
After matching frail and nonfrail participants for the retrospect-
ive analysis, the average age for onset of frailty was 83.7 years in 
LASA and 82.1 years in InCHIANTI (Supplementary Table 2). The 
respective ages for nonfrail participants at the end of follow-up were 
83.0 and 80.6 years. Frailty was more common in women than in 
men in both study cohorts, proportion of women being 57% in 
LASA and 64% in InCHIANTI. In the LASA study, participants who 
did not develop frailty during the follow-up provided data from 3.8 
(SD 1.5) and those who developed frailty participated in 3.5 (SD 
1.4) of the possible six study waves. In the InCHIANTI study, the 
corresponding mean numbers were 3.5 (SD 0.8) and 3.1 (SD 0.8) of 
the possible four study waves.
Overall, the development of frailty components was very simi-
lar in the two cohorts, and accumulation of frailty components 
increased gradually over the years toward the onset of frailty 
(Figure  3, Supplementary Figure  1). On average, the number of 
frailty components was 1.2 in LASA and 1.0 in InCHIANTI 3 years 
before onset of frailty. The corresponding numbers for participants 
who did not develop frailty during the follow-up were 0.8 in LASA 
and 0.6 in InCHIANTI, 3 years before the end of follow-up. Of the 
frailty components, weakness was most prevalent and weight loss 
least prevalent in LASA and exhaustion most prevalent and weight 
loss least prevalent in InCHIANTI (Supplementary Figure 2).
Estimated prevalence of each of the frailty components among 
frail and nonfrail participants during 9- to 15-year time window prior 
to onset of frailty are shown in Figure 4, and comparison between 
frail and nonfrail participants at different time points are shown 
in Table 1. These results are based on pooled analyses (cohort-spe-
cific results are shown in Supplementary Figure 2). Among the five 
frailty components, exhaustion separated frail and nonfrail groups 
already 9 years prior to onset of frailty, the pooled RR being 1.53 
(95% CI 1.04–2.24) at that time point. The prevalence of exhaus-
tion remained relatively constant in frail and nonfrail groups over 
the years but increased markedly in the frailty group during the last 
Figure 3. Number of frailty components (mean and 95% confidence intervals) 
among frail and matched nonfrail participants during the 15 years prior to 
onset of frailty (year 0). For nonfrail participants, year 0 is the last available 
measurement wave. Pooled analysis of the LASA and InCHIANTI studies. 
Values from years −15 to −12 are from the LASA study only. Models adjusted 
for age (year 0), sex, and education.
Figure  4. Estimated prevalence and 95% confidence intervals of frailty 
components among frail and matched nonfrail participants during the 
15  years prior to onset of frailty (year 0). For nonfrail participants, year 0 
is the last available measurement wave. Pooled analysis of the LASA and 
InCHIANTI studies. Values from years −15 to −12 are from the LASA study 
only. Models adjusted for age (year 0), sex, and education.
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3 years of follow-up. At the end of the follow-up, the prevalence of 
that component was four times higher in frailty participants (pooled 
RR 3.96, 95% CI 3.27–4.79) than nonfrail participants.
Slowness, low activity, and weakness separated frail and non-
frail groups 6  years prior to onset of frailty. The pooled RRs for 
these components were 1.94 (95% CI 1.44–2.61), 1.59 (95% CI 
1.19–2.13), and 1.39 (95% CI 1.10–1.76), respectively. In contrast 
to exhaustion, prevalence of slowness, low activity, and weakness 
increased gradually with increasing age both in the frail and nonfrail 
groups. At the end of the follow-up, frail participants reported 3.4 
times (pooled RR 3.39, 95% CI 2.88–3.98) more often slowness, 2.7 
times (pooled RR 2.73, 95% CI 2.37–3.13) more often low activ-
ity, and 2.4 times (pooled RR 2.39, 95% CI 2.09–2.73) more often 
weakness than nonfrail participants.
Weight loss did not separate frail and nonfrail groups before 
onset of frailty. However, when comparing prevalence of weight loss 
at the end of the follow-up, the prevalence of weight loss was more 
than three times higher in frail participants compared with those 
who did not develop frailty (pooled RR 3.36, 95% CI 2.76–4.08).
In a sensitivity analysis including only participants with at least 
9-year follow-up data (LASA, n = 397 and InCHIANTI, n = 307), 
the overall development of frailty components was very similar to 
that seen in the main results (Supplementary Figure  3). In terms 
of the individual frailty components (Supplementary Figure 4 and 
Supplementary Table  3), exhaustion separated frail and nonfrail 
groups 9 years and slowness and low activity 6 years prior to onset 
of frailty, as in the main results. Weakness showed moderate evi-
dence in separating frail and nonfrail groups 3 years prior to onset 
of frailty, which was 3 years later than in the main results. Weight 
loss did not separate frail and nonfrail groups before onset of frailty 
as in the main results.
Discussion
This analysis, based on two independent well-characterized cohort 
studies, described the progression of frailty and characterized the 
sequence of emergence of its components over 9–15  years before 
onset of frailty. We found that participants who developed frailty, 
reported more often exhaustion already 9 years and slowness, low 
activity, and weakness 6 years prior to onset of frailty than those 
who remained free of frailty during the follow-up. In contrast, the 
fifth frailty component, weight loss, did not separate frail and non-
frail groups before onset of frailty. The findings were similar in the 
two cohorts.
The main strength of this prospective study is repeated measure-
ments of all five frailty components up to 9 to 15 years and the use of 
data from two large, independent cohorts from Europe. This allowed 
us to identify the time points when prevalence of different frailty 
criteria begins to diverge between those who subsequently developed 
frailty and those who remained free of frailty. Another strength was 
the possibility to assess the similarities and differences of the obser-
vations between two different cohorts, an important point regarding 
the generalizability of our findings to other countries. The participa-
tion rate was high, and on average, the participants provided data 
on more than three time points. Finally, the similar study design and 
nearly identically measured frailty criteria allowed us to pool the 
results from two different cohorts to obtain more robust results.
The finding that exhaustion was the first frailty indicator that 
separated persons who subsequently developed frailty and those 
who remained free of frailty is novel. To our knowledge, only one 
previous study (the Women’s Health and Aging Study II, WHAS II) 
has attempted to examine manifestation of individual frailty compo-
nents before onset of frailty (16). In that study, based on relatively 
small sample of incident frailty cases, exhaustion was found to be 
among the last components to occur. Direct comparison between 
our and WHAS II findings is not, however, meaningful because 
InCHIANTI and LASA are population-based studies, whereas 
WHAS II participants were initially relatively high-functioning 
women. The discrepancy to our findings may also lie on different 
measures of exhaustion. The WHAS II study defined exhaustion by 
low energy level or feeling tiredness and weakness most of the time. 
In our study, exhaustion was measured with two items drawn from 
the Center for Epidemiology Studies-Depression (CES-D) scale (25): 
“I felt that everything I did was an effort in the last week” and “I 
could not get going in the last week.” Both items have previously also 
been used as general measures of fatigue (26). Fatigue is complex 
and multidimensional concept involving a sensation of ‘‘low energy” 
and disturbed energy balance (27). Given this, our finding is biologi-
cally plausible. Perceived global fatigue, an overall subjective lack 
of physical or mental energy, may limit physical activity and lead to 
sedentary behavior, which further deteriorates physical functioning 
and, over time, increases the risk of functional limitation and mortal-
ity (27–30). As a distal risk factor in the causal chain, perception of 
exhaustion or fatigue has been hypothesized to be one of the early 
markers identifying people at frailty risk (31). Our findings, support-
ing this hypothesis, suggest that early identification of exhaustion 
and fatigue in apparently physically well-functioning older adults 
might help to identify persons in the initial stages of frailty allowing 
timely interventions to prevent development of frailty.
Other frailty components that related to early differences 
between the frail and nonfrail were slowness, low activity, and 
weakness. These criteria mostly reflect the physical determinants of 
frailty and are quite interrelated with each other. Distinctive in these 
frailty criteria compared with exhaustion and weight loss criteria 
was that the prevalence increased gradually with time among both 
frail and nonfrail participants, but the increment became greater in 
the frailty group 6 years before onset of frailty. Walking speed, phys-
ical activity, and muscle strength all decline with age, and therefore, 
it is understandable that also nonfrail participants show decline in 
these conditions, although to a lesser extent than individuals who 
develop frailty later. Prevalence of slowness, low activity, and weak-
ness was about 70% at the time of onset of frailty suggesting that 
these physical characteristics commonly characterize people with 
frailty. Our finding is in agreement with previous study showing 
that weakness often co-occurs with slowness or low physical activ-
ity (16).
Weight loss is often seen as an important component of the frailty 
syndrome resulting possibly from energy dysregulation, reduction of 
appetite, and food intake (32). That weight loss differentiated frail 
and nonfrail persons only at the onset of frailty (ie, the last measure-
ment point) suggests weight loss is a late component in the process 
leading to development of frailty and thus not necessarily inform-
ative for early detection of risk groups. Similarly, with our study, Xue 
and colleagues observed that weight loss was the last frailty compo-
nent to emerge before onset of frailty (16). However, based on our 
findings, it is also possible that weight loss is a consequence of frailty 
rather than a causal factor. Future research is needed to disentangle 
the temporal order of weight loss and frailty.
Our findings suggest that screening for exhaustion and other 
components of frailty in persons aged 70 years and older could be 
warranted. Fried’s phenotypic model (1), which was used in the cur-
rent study, is suggested to be one suitable screening test. Identification 
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of frailty components on time is pivotal for implementing preven-
tive interventions to stop or slow down the development of frailty. 
These findings also suggest that a sense of exhaustion may be the 
trigger to behavioral changes, such as being less physically active, 
which predisposes a vicious cycle that eventually leads to frailty. 
Interventions aimed at counteracting such behavioral changes in 
people who already feel exhausted may slow down this process and 
possibly prevent frailty.
This study has some limitations that warrant discussion. Due to 
the 3-year measurement interval, we were unable to define the precise 
year when frailty emerged. Thus, for some people −3 year could in 
fact be −1 (before frailty onset), and therefore, the differences found 
in time point −3 would be overestimated. However, the main interest 
in this study was the whole 15 years prior to onset of frailty, and we 
feel that the findings related to early differentiation among frail and 
nonfrail are relatively accurate. It is also worth noting that people in 
the “nonfrail” group may have developed frailty after the end of the 
follow-up and thus were already prefrail during the examined study 
period. This, however, rather underestimates than overestimates the 
observed differences between frail and nonfrail at different time 
points. Attrition is typical in longitudinal studies, including LASA 
and InCHIANTI in which about half of the participants remained in 
the study at least for 9 years. To explore the effect of attrition to our 
findings, we conducted sensitivity analyses and were able to replicate 
the main findings, suggesting attrition is not a major source of bias 
in our analyses. Finally, multiple instruments have been developed 
to measure frailty, but frailty does not yet have an internationally 
recognized standard definition (33). In this study, Fried’s pheno-
typic model was used and both studies had measured the required 
five components shown to predict adverse health outcomes such as 
falls, disability, and death (4,5). The advantage of Fried’s phenotypic 
model is that it is mostly based on objective testing compared with 
some other tools relying on subjective evaluations.
In conclusion, to the best of our knowledge, this is the first large-
scale study based on representative population samples to examine 
longitudinally the development of frailty criteria over 9 to 15 years 
of follow-up among initially nonfrail or prefrail participants. We 
found evidence suggesting that older adults who develop frailty 
Table 1. Risk Ratios (RRs) and Their 95% Confidence Intervals (CI) for Each Frailty Components Comparing Frail and Matched Nonfrail at 
Different Time Points Prior the Onset of Frailty (Year 0) in the LASA (N = 816) and InCHIANTI (N = 553) Studies
Years Prior to Frailty Onset
LASA InCHIANTI Pooled Summary Estimates
RR 95% CI RR 95% CI RR 95% CI
Exhaustion
 −15 1.47 0.56 3.83 1.47 0.56 3.83
 −12 1.15 0.48 2.75 1.15 0.48 2.75
 −9 1.82 0.96 3.44 1.43 0.88 2.30 1.53 1.04 2.24
 −6 2.18 1.29 3.69 1.95 1.38 2.75 2.02 1.51 2.69
 −3 1.71 1.11 2.63 2.13 1.53 2.96 1.96 1.51 2.55
 0 5.03 3.76 6.73 3.31 2.57 4.26 3.96 3.27 4.79
Slowness
 −15 1.36 0.41 4.50 1.36 0.41 4.50
 −12 1.00 0.43 2.29 1.00 0.43 2.29
 −9 1.31 0.78 2.19 1.68 0.81 3.47 1.42 0.93 2.17
 −6 1.59 1.11 2.26 3.07 1.79 5.27 1.94 1.44 2.61
 −3 1.60 1.24 2.07 3.09 2.07 4.60 1.94 1.56 2.41
 0 2.87 2.38 3.46 5.39 3.93 7.38 3.39 2.88 3.98
Low activity
 −15 2.29 0.85 6.15 2.29 0.85 6.15
 −12 1.57 0.81 3.07 1.57 0.81 3.07
 −9 1.44 0.85 2.46 0.87 0.36 2.07 1.26 0.8 1.98
 −6 1.53 1.04 2.23 1.68 1.07 2.64 1.59 1.19 2.13
 −3 1.58 1.21 2.06 1.43 1.10 1.87 1.5 1.24 1.81
 0 3.15 2.58 3.86 2.39 1.97 2.89 2.73 2.37 3.13
Weakness
 −15 0.77 0.32 1.84 0.77 0.32 1.84
 −12 1.28 0.84 1.95 1.28 0.84 1.95
 −9 1.36 0.96 1.92 0.89 0.50 1.59 1.21 0.9 1.63
 −6 1.30 1.00 1.70 1.81 1.07 3.07 1.39 1.1 1.76
 −3 1.61 1.33 1.95 1.28 0.85 1.94 1.55 1.3 1.84
 0 2.31 1.97 2.70 2.61 2.01 3.37 2.39 2.09 2.73
Weight loss
 −15 0.96 0.13 7.18 0.96 0.13 7.18
 −12 1.36 0.64 2.90 1.36 0.64 2.90
 −9 1.09 0.61 1.97 0.50 0.19 1.33 0.84 0.5 1.39
 −6 1.33 0.87 2.03 0.91 0.58 1.42 1.11 0.81 1.51
 −3 0.62 0.40 0.97 0.77 0.46 1.29 0.68 0.49 0.95
 0 3.05 2.41 3.87 4.13 2.91 5.86 3.36 2.76 4.08
For nonfrail participants, year 0 is the last available measurement wave.
Note: Models adjusted for age (year 0), sex, and education.
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tend to report exhaustion quite early, approximately 9 years prior 
to onset of frailty compared with those who remain free of frailty. 
In addition, slowness, low activity, and weakness differentiated 
frailty and nonfrail groups from each other already 6 years before 
onset of frailty. In contrast, a typical feature of frailty, weight loss, 
was observed to take place only in the last years preceding onset 
of frailty. Further research is needed to examine the generalizability 
of our findings and to evaluate whether routine screening of frailty 
components could improve cost-effectiveness of interventions to pre-
vent or delay frailty by targeting earlier those individuals who are at 
the greatest risk.
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